141 related articles for article (PubMed ID: 9192799)
21. Immunologic classification of acute lymphoblastic leukemia.
Cabrera ME
Am J Pediatr Hematol Oncol; 1990; 12(3):283-91. PubMed ID: 2240474
[TBL] [Abstract][Full Text] [Related]
22. [Immunophenotyping of acute lymphoblastic leukemia in Mexican children].
Paredes-Aguilera R; Romero-Guzmán L; López-Santiago N; Bravo-Lindoro A; Correa-González C; Joly-Linero R; Nieto-Martínez S; del Campo-Martínez A
Sangre (Barc); 1999 Jun; 44(3):188-94. PubMed ID: 10481579
[TBL] [Abstract][Full Text] [Related]
23. Chronic myelomonocytic leukemia derived from a possible common progenitor of monocytes and natural killer cells.
Kojima H; Bai A; Mukai HY; Hori M; Komeno T; Hasegawa Y; Ninomiya H; Mori N; Nagasawa T
Leuk Lymphoma; 2000 May; 37(5-6):617-21. PubMed ID: 11042523
[TBL] [Abstract][Full Text] [Related]
24. Leukemia and lymphoma of natural killer lineage cells.
Oshimi K
Int J Hematol; 2003 Jul; 78(1):18-23. PubMed ID: 12894846
[TBL] [Abstract][Full Text] [Related]
25. CD7+ and CD56+ myeloid/natural killer cell precursor acute leukemia treated with idarubicin and cytosine arabinoside.
Handa H; Motohashi S; Isozumi K; Komatsumoto S; Nara M
Acta Haematol; 2002; 108(1):47-52. PubMed ID: 12145468
[TBL] [Abstract][Full Text] [Related]
26. Immunophenotypic classification of acute lymphoblastic leukaemia.
Ludwig WD; Raghavachar A; Thiel E
Baillieres Clin Haematol; 1994 Jun; 7(2):235-62. PubMed ID: 7803900
[No Abstract] [Full Text] [Related]
27. Clinical, immunophenotypic and genomic findings of NK lymphoblastic leukemia: a study from the Bone Marrow Pathology Group.
Weinberg OK; Chisholm KM; Ok CY; Fedoriw Y; Grzywacz B; Kurzer JH; Mason EF; Moser KA; Bhattacharya S; Xu M; Babu D; Foucar K; Tam W; Bagg A; Orazi A; George TI; Wang W; Wang SA; Arber DA; Hasserjian RP
Mod Pathol; 2021 Jul; 34(7):1358-1366. PubMed ID: 33526873
[TBL] [Abstract][Full Text] [Related]
28. A case of primary cutaneous CD56+, TdT+, CD4+, blastic NK-cell lymphoma in a 19-year-old woman.
Chang SE; Choi HJ; Huh J; Choi JH; Sung KJ; Moon KC; Koh JK
Am J Dermatopathol; 2002 Feb; 24(1):72-5. PubMed ID: 11803287
[TBL] [Abstract][Full Text] [Related]
29. CD94 1A transcripts characterize lymphoblastic lymphoma/leukemia of immature natural killer cell origin with distinct clinical features.
Lin CW; Liu TY; Chen SU; Wang KT; Medeiros LJ; Hsu SM
Blood; 2005 Nov; 106(10):3567-74. PubMed ID: 16046525
[TBL] [Abstract][Full Text] [Related]
30. CD10/common acute lymphoblastic leukemia-associated antigen and adhesion factor expression is predictive for lymphokine-activated killing sensitivity of adult B-lineage acute lymphoblastic leukemia.
Correale P; Tagliaferri P; Camera A; Caraglia M; Del Vecchio L; De Laurentis M; Pinto A; Rotoli B; Bianco AR
Year Immunol; 1993; 7():90-5. PubMed ID: 7690510
[No Abstract] [Full Text] [Related]
31. [Retrospective analysis of 4 cases of the so-called blastic NK-cell lymphoma, with reference to the 2008 WHO classification of tumours of haematopoietic and lymphoid tissues].
Zheng YY; Chen G; Zhou XG; Jin Y; Xie JL; Zhang SH; Zhang YN
Zhonghua Bing Li Xue Za Zhi; 2010 Sep; 39(9):600-5. PubMed ID: 21092587
[TBL] [Abstract][Full Text] [Related]
32. CD34, FasR, Bcl-2, apoptotic index and DNA index in acute lymphoblastic leukaemia in adults.
Pietruczuk M; Dabrowska M; Osada J; Kostecka I; Suchowierska M; Kłoczko J
Leuk Lymphoma; 2003 Mar; 44(3):553-6. PubMed ID: 12688333
[No Abstract] [Full Text] [Related]
33. Thymic lymphoblastic lymphoma of committed natural killer cell precursor origin: a case report.
Ichinohasama R; Endoh K; Ishizawa K; Okuda M; Kameoka J; Meguro K; Myers J; Kadin ME; Mori S; Sawai T
Cancer; 1996 Jun; 77(12):2592-603. PubMed ID: 8640711
[TBL] [Abstract][Full Text] [Related]
34. A primitive hematopoietic cell is the target for the leukemic transformation in human philadelphia-positive acute lymphoblastic leukemia.
Cobaleda C; Gutiérrez-Cianca N; Pérez-Losada J; Flores T; García-Sanz R; González M; Sánchez-García I
Blood; 2000 Feb; 95(3):1007-13. PubMed ID: 10648416
[TBL] [Abstract][Full Text] [Related]
35. CRTAM
Ramírez-Ramírez D; Padilla-Castañeda S; Galán-Enríquez CS; Vadillo E; Prieto-Chávez JL; Jiménez-Hernández E; Vilchis-Ordóñez A; Sandoval A; Balandrán JC; Pérez-Tapia SM; Ortiz-Navarrete V; Pelayo R
J Leukoc Biol; 2019 May; 105(5):999-1013. PubMed ID: 30791148
[TBL] [Abstract][Full Text] [Related]
36. A new human natural killer leukemia cell line, IMC-1. A complex chromosomal rearrangement defined by spectral karyotyping: functional and cytogenetic characterization.
Chen IM; Whalen M; Bankhurst A; Sever CE; Doshi R; Hardekopf D; Montgomery K; Willman CL
Leuk Res; 2004 Mar; 28(3):275-84. PubMed ID: 14687623
[TBL] [Abstract][Full Text] [Related]
37. Flow cytometric immunophenotyping is of great value to diagnosis of natural killer cell neoplasms involving bone marrow and peripheral blood.
Jiang NG; Jin YM; Niu Q; Zeng TT; Su J; Zhu HL
Ann Hematol; 2013 Jan; 92(1):89-96. PubMed ID: 22992980
[TBL] [Abstract][Full Text] [Related]
38. A child case of CD34+, CD33-, HLA-DR-, CD7+, CD56+ stem cell leukemia with thymic involvement.
Nagata T; Higashigawa M; Nagai M; Zhang XL; Azuma E; Komada Y; Sakurai M
Leuk Res; 1996; 20(11-12):983-5. PubMed ID: 9009257
[TBL] [Abstract][Full Text] [Related]
39. CD56+ hematologic malignancies.
Loughran TP
Leuk Res; 1999 Jul; 23(7):675-6. PubMed ID: 10400189
[No Abstract] [Full Text] [Related]
40. Natural killer cell neoplasm: biology and pathology.
Ham MF; Ko YH
Int J Hematol; 2010 Dec; 92(5):681-9. PubMed ID: 21132576
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
